Navigation Links
The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers
Date:4/6/2009

>College of Medicine and SALSA

The Southern Arizona Limb Salvage Alliance (SALSA) at the University of Arizona College of Medicine is dedicated to amputation prevention and healing in persons with diabetes. Its mission is to advance current knowledge regarding assessment and treatment of the diabetic foot and its related diseases/complications, which include ulceration, infection, peripheral vascular disease, neuropathic arthropathy and amputation.

Furthermore, the alliance assesses the impact of these maladies on society and, commensurately, the impact of potential treatments or assessment techniques. SALSA seeks to deliver practical clinical solutions to clinicians and their patients in the developed and developing world.

About OmegaGenesis

OmegaGenesis, Inc., is a nanotechnology company based in California and Minnesota. The company is the market innovator in nanotechnology-based angiogenesis and imaging solutions. Its solutions promote the growth of new blood vessels where needed to improve human health.

The company was founded in 2008 to bring Mayo Clinic-proprietary nanomaterial technology to the marketplace. The technology and products are based on the idea that controlling blood-vessel growth will improve human body management for a diverse set of medical applications, ranging from common wound healing to tissue reactivation.

OmegaGenesis is the pioneer in using nutrient enhancement through new capillary growth to heal wounds and activate dormant cells. Its research has led to production of nano-scale materials that work on the cellular and sub-cellular level to promote or inhibit angiogenesis, the growth of new blood vessels.

The company's mission emphasizes collaborative research in partnership with leading medical centers, rapid product design, development and validation. OmegaGenesis collaborates wit
'/>"/>

SOURCE OmegaGenesis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015  Prima Biomed Ltd. (NASDAQ: PBMD ... to become a leader in the development of immunotherapeutic ... the final CVac data from the Phase II CAN-003 ... for a clinically meaningful improvement in Overall Survival ("OS") ... In the group of second remission patients ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... May 21, 2015 W. R. ... manufacturing facility in Worms, Germany has received good ... subsidiary of the International Pharmaceutical Excipient Council (IPEC) ... that produce its SYLOID® FP brand of pharmaceutical ... certification, following the Curtis Bay, Maryland (USA) and ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... The University of California, Riverside has received a $1.85 ... that is beyond the scope of conventional silicon electronics. ... speed up applications that process large amounts of data ... The money is awarded to UC Riverside under ...
... Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced ... with its new dietary supplement containing bovine protein extract, ... immunity in animals and people. Because animal shelters co-mingle ... control viral respiratory infections as well as diarrhea and ...
... CLEVELAND, Oct. 5, 2011 DATATRAK International, Inc. (OTCQX: ... eClinical solutions for the clinical trials industry, today announced ... specialty biologics and vaccines company.  Recognizing the value of ... ONE™ unified software suite to conduct a series of ...
Cached Biology Technology:Physicists to develop new way of electronic computing 2Amarillo Biosciences Teams with Animal Shelters to Improve Health and Enhance Immunity of Cats and Dogs 2DATATRAK Signs Multi-Year Agreement with Specialty Biotech 2
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... radioactive "guided missiles," researchers at the Albert Einstein College ... destroyed human immune cells infected with HIV, the virus ... supports the idea that radioimmunotherapy might help in treating ... of the department of microbiology and immunology at Einstein ...
... by Queensland University of Technology is helping scientists better understand ... the development of technology that can speed up the time ... recent graduate Dr Gwynne Hannay has built a gadget capable ... Dr Hannay said his device replicated the mechanical and electrical ...
... California, San Diego have discovered that the presence of a ... (which glow at center due to a fluorescent protein) allows ... its 800 unit eyes, an evolutionary change to an "open ... acuity and angular sensitivity. In contrast, beetles (shown surrounding the ...
Cached Biology News:Einstein researchers demonstrate a novel approach to treating AIDS 2Einstein researchers demonstrate a novel approach to treating AIDS 3Smashing the time it takes to repair our bones 2
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
...
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: